Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation

Gynecologic Oncology

Volumn 114, Issue 1, 2009, Pages 69-74

  Kasamatsu, Takahiro ^a   Onda, Takashi ^a   Sawada, Morio ^a   Kato, Tomoyasu ^a   Ikeda, Shun ichi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cervical cancer; FIGO stage IIB; Prognostic factor; Radical hysterectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOMETRIUM; PELVIS LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; SURVIVORS; UTERINE CERVICAL NEOPLASMS;

EID: 67349100937     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.026     Document Type: Article

References (32)

1. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P.M., et al. Carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet. 83 Suppl 1 (2003) 41-78
2. National Cancer Institute. Cervical cancer treatment. (http://www.cancer.gov/cancertopics/pdq/treatment/cervical/healthprofessional) [Accessed December 15, 2008].
3. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 (1999) 1339-1348
4. Morris M., Eifel P.J., Lu J., Grygsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340 (1999) 1137-1143
5. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 (1999) 1144-1153
6. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 (1999) 1154-1161
7. Peters III W.A., Liu P.Y., Barrett II R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 (2000) 1606-1613
8. Pearcey R., Brundage M., Drouin P., Jeffrey J., Johnston D., Lukka H., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J. Clin. Oncol. 20 (2002) 966-972
9. Okabayashi H. Radical abdominal hysterectomy for cancer of the cervix uteri. Surg. Gynecol. Obstet. 33 (1921) 335-341
10. Suprasert P., Srisomboon J., and Kasamatsu T. Radical hysterectomy for stage IIB cervical cancer: a review. Int. J. Gynecol. Cancer. 15 (2005) 995-1001
11. Sobin L.H. Wittekind Ch. TNM Classification of Malignant Tumours. 6th ed (2002), Wiley-Liss, New York
12. Scully R.E., Bonfigiro T.A., Kurman R.J., Silverberg S.G., and Wilkinson E.J. Histological Typing of female Genital Tract Tumors. 2nd ed (1994), Springer-Verlag, Berlin Heidelberg
13. Yamada T., and Chitose K. Radical hysterectomy. In: Suemasu K., and Sonoda T. (Eds). Surgical Oncology-Operative techniques volume 11 (1994), Medical View, Tokyo 20-69
14. Kobayashi T. Abdominal Radical Hysterectomy with Pelvic Lymphadenectomy for Cancer of the Cervix (1961), Nanzando, Tokyo
15. Sakamoto S. Radical hysterectomy with pelvic lymphadenectomy-the Tokyo method. In: Malcom C. (Ed). Gynecologic Oncology volume 2 (1981), Churchill Livingstone, New York 877-886
16. The Gynecological Cancer Committee of the Japan Society of Obstetrics and Gynecology. General Rules for Clinical and Pathological Study of Uterine Cervical Cancer in Japan (1994), Kanehara, Tokyo
17. Matsuyama T., Inoue I., Tsukamoto N., Kashimura M., Kamura T., Saito T., et al. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis. Cancer 54 (1984) 3072-3077
18. Inoue T., and Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation. Cancer 54 (1984) 1714-1719
19. Burghardt E., Pickel H., Haas J., and Lahousen M. Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Am. J. Obstet. Gynecol. 156 (1987) 988-996
20. Girardi F., Lichtenegger W., Tamussino K., and Haas J. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol. Oncol. 34 (1989) 206-211
21. Inoue T., and Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 65 (1990) 1923-1927
22. Kamura T., Tsukamoto N., Tsuruchi N., Kaku T., Saito T., To N., et al. Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection - an analysis with mathematical statistics. Int. J. Gynecol. Cancer. 3 (1993) 219-225
23. Kawagoe T., Kashimura M., Matsuura Y., Sugihara K., Toki N., and Aoki T. Clinical significance of tumor size in stage IB and II carcinoma of the uterine cervix. Int. J. Gynecol. Cancer. 9 (1999) 421-426
24. Okada M., Kigawa J., Minagawa Y., Kanamori Y., Shimada M., Takahashi M., et al. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer. Gynecol. Oncol. 70 (1998) 61-64
25. Sakuragi N., Satoh C., Takeda N., Hareyama H., Takeda M., Yamamoto R., et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 (1999) 1547-1554
26. Aoki Y., Sasaki M., Watanabe M., Sato T., Tsuneki I., Aida H., et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol. Oncol. 77 (2000) 305-309
27. Trattner M., Graf A.H., Lax S., Forstner R., Dandachi N., Hass J., et al. Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol. Oncol. 82 (2001) 11-16
28. Takeda N., Sakuragi N., Takeda M., Okamoto K., Kuwabara M., Negishi H., et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta. Obstet. Gynecol. Scand. 81 (2002) 1144-1151
29. Noguchi H., Shiozawa I., Sakai Y., Yamazaki T., and Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol. Oncol. 27 (1987) 150-158
30. Yamashita H., Nakagawa K., Tago M., Shiraishi K., Nakamura N., Ohtomo K., et al. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study. Gynecol. Oncol. 97 (2005) 834-839
31. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet. Gynecol. 44 (1974) 265-272
32. Ohara K., Sugahara S., Kagei K., Hata M., Hiroshi I., Tokuuye K., et al. Retrospective comparison of clinical outcome between radiotherapy alone and surgery plus postoperative radiotherapy in the treatment of stages IB-IIB cervical squamous cell carcinoma. Radiat. Med. 22 (2004) 42-48